SALIM VIRANI to Ambulatory Care
This is a "connection" page, showing publications SALIM VIRANI has written about Ambulatory Care.
Connection Strength
1.882
-
Effectiveness of NPs and PAs in managing diabetes and cardiovascular disease. JAAPA. 2018 Jul; 31(7):39-45.
Score: 0.462
-
Health Care Resource Utilization for Outpatient Cardiovascular Disease and Diabetes Care Delivery Among Advanced Practice Providers and Physician Providers in Primary Care. Popul Health Manag. 2018 06; 21(3):209-216.
Score: 0.440
-
National trends and disparities in statin use for ischemic heart disease from 2006 to 2018: Insights from National Ambulatory Medical Care Survey. Am Heart J. 2022 10; 252:60-69.
Score: 0.151
-
Surfing the Waves of the COVID-19 Pandemic as a Cardiovascular Clinician. Circulation. 2020 07 14; 142(2):98-100.
Score: 0.131
-
Trends in U.S. Ambulatory Cardiovascular Care 2013 to 2017: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 01 07; 75(1):93-112.
Score: 0.128
-
Relation Between Cardiology Follow-Up Visits, Evidence-Based Statin Prescribing, and Statin Adherence (from the Veterans Affairs Health Care System). Am J Cardiol. 2019 10 15; 124(8):1165-1170.
Score: 0.124
-
Provider-Level Variation in Smoking Cessation Assistance Provided in the Cardiology Clinics: Insights From the NCDR PINNACLE Registry. J Am Heart Assoc. 2019 07 02; 8(13):e011412.
Score: 0.124
-
Comparative effectiveness of outpatient cardiovascular disease and diabetes care delivery between advanced practice providers and physician providers in primary care: Implications for care under the Affordable Care Act. Am Heart J. 2016 Nov; 181:74-82.
Score: 0.102
-
Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program. Clin Cardiol. 2016 Mar; 39(3):145-9.
Score: 0.098
-
Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry. J Am Coll Cardiol. 2015 Oct 20; 66(16):1803-1812.
Score: 0.096
-
Implications of the LEGACY trial on US Atrial Fibrillation Patients: An NCDR Research to Practice (R2P) Project. Am J Cardiol. 2017 02 15; 119(4):579-584.
Score: 0.026